The startup has developed a wearable medical device that utilizes novel optoelectronics technology to achieve high-resolution imaging of the body and brain, effectively replacing traditional MRI functionality. This device generates reconstructive holographic images that minimize scattering, enabling precise manipulation or destruction of individual cells without damaging surrounding tissue, thereby enhancing diagnostic and treatment capabilities for various diseases.
Funding
$94M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current MRI technology is expensive, bulky, and confined to clinical settings, limiting accessibility and hindering frequent monitoring for various diseases. Traditional methods also lack the precision to target individual cells without affecting surrounding healthy tissue.
Solution
Openwater is developing portable, non-invasive medical devices utilizing infrared light and ultrasound to diagnose and treat diseases with greater precision and accessibility. Their technology manipulates the phase of light, ultrasound, and electromagnetic waves to enable the selective manipulation or destruction of individual cells, minimizing harm to surrounding tissue. The company's open-source approach aims to accelerate innovation and reduce costs, making treatments more accessible. Openwater's platforms, Open-Motion and Open-LIFU, are designed as modular systems that can be configured for various research applications, including blood flow measurement, neuromodulation, and oncolysis.
Target Audience
The primary target audience includes researchers and research institutions focused on developing new diagnostic and therapeutic methods for diseases such as cancer, mental health disorders, and stroke.
Features
- Open-Motion: Measures blood flow index, blood volume index, micro-motion, and oxygenation using low-intensity near-infrared light and holographic detection.
- Open-LIFU: A low-intensity focused ultrasound therapy platform for neuromodulation and cancer treatment.
- Targeted cell manipulation: Selectively targets diseased cells without harming surrounding tissue.
- Non-invasive approach: Utilizes infrared light and ultrasound, avoiding ionizing radiation or pharmaceuticals.
- Open-source technology: Accelerates innovation and drives down costs through collaborative development.
- Modular design: Configurable systems optimized for specific research applications.
- Compact and portable: Designed to be more accessible than traditional MRI machines.